César Alejandro
Soutullo Esperón
Investigador hasta 2019
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (4)
2018
2014
-
Expert Recommendation: Contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD)
Actas Espanolas de Psiquiatria, Vol. 42, pp. 1-16
2012
-
Altered default network resting state functional connectivity in patients with a first episode of psychosis
Schizophrenia Research, Vol. 139, Núm. 1-3, pp. 13-18
-
Genetic bases of attention deficit hyperactivity disorder
Revista de Neurologia, Vol. 55, Núm. 10, pp. 609-618